Last update 05 Feb 2026

NCB-003

Overview

Basic Info

Drug Type
Recombinant protein
Synonyms
NCB 003, NCB-003, NCB003
Target
IL-2
Action-
Mechanism
IL-2 replacements(Interleukin-2 replacements)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid Neoplasm
Inactive Indication-
Originator Organization
NovoCodex Biopharmaceuticals Co., Ltd.NovoCodex Biopharmaceuticals Co., Ltd.
Active Organization
NovoCodex Biopharmaceuticals Co., Ltd.NovoCodex Biopharmaceuticals Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with NCB-003
CTR20260365
/ Not yet recruitingPhase 1
注射用NCB003在晚期恶性实体瘤患者中的安全性、耐受性、药代动力学特征及初步有效性的开放、多中心、I期临床研究
[Translation] An open-label, multicenter, phase I clinical study of the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of NCB003 for injection in patients with advanced malignant solid tumors.
100 Clinical Results associated with NCB-003
Login to view more data
100 Translational Medicine associated with NCB-003
Login to view more data
100 Patents (Medical) associated with NCB-003
Login to view more data
100 Deals associated with NCB-003
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
China
NovoCodex Biopharmaceuticals Co., Ltd.NovoCodex Biopharmaceuticals Co., Ltd.
04 Feb 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free